This Vienna firm is known in the market for its litigation and advisory work for international companies from the life sciences sector. The team nurtures a full-service approach and does not specialise on IP alone. The growing demand for advice on the interface with regulatory issues plays a key role. In patents, litigation for MSD in economically high-stakes proceedings is one of the practice highlights.
The team works closely with market-leading firms in other European jurisdictions here. In unfair competition, Daiichi Sankyo is on the regular client list. Following a reorganisation and renaming of the firm in 2019, the IP team lost a lawyer specialising in trademarks to a company at the end of 2020. A young lawyer has now taken over trademark registration work.
3 partners, 4 associates, 4 trainee lawyers
Comprehensive advice in IP, especially soft IP. In patents, mainly infringement and nullity suits over pharma patents.
Litigation: MSD against generic manufacturer over cholesterol-lowering drug Inegy; MSD against Hoffmann-La Roche over Herceptin.